Registration Decision RD2021-06, Fluazaindolizine and Salibro Nematicide
This decision is consistent with the Proposed Registration Decision PRD2021-03, Fluazaindolizine and Salibro Nematicide, whichcontains a detailed evaluation of the information submitted in support of this registration.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2023-03-28
Data overview
- Formats
- HTML
- File languages
- English, French